Abstract
Plasma nicotine concentrations following subcutaneous (SC) injection were measured in six subjects who included three life-long nonsmokers. On average, a peak plasma level of 8.5 ng/ml (SD=3.1) was reached 15 min after the mean dose of 13.25 µg/kg nicotine base. Subjective effects were reported by five subjects. The peak heart rate response (mean boost 11 beats per min at 10 min) preceded and was already declining by the time plasma nicotine concentrations peaked. Hysteresis plots showed clear evidence of acute nicotine tolerance in subjects who had never smoked, indicating that acute tolerance is not an acquired phenomenon. The acquisition by smokers of chronic tolerance to nicotine has not yet been systematically demonstrated. Reliable dose-response studies in smokers and nonsmokers are needed, and use of the SC route for this purpose is discussed.
Similar content being viewed by others
References
Benowitz NL, Jacob P, Jones RT, Rosenberg J (1982) Inter-individual variability in metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221:368–372
Feyerabend C, Russell MAH (1980) Assay of nicotine in biological materials: sources of contamination and their elimination. J Pharm Pharmacol 32:178–181
Langley JN, Dickinson WL (1889) On the local paralysis of peripheral ganglia, and on the connection of different classes of nerve fibres with them. Proc R Soc Lond 46:423–431
Murphree HD (1979) EEG effects in humans of nicotine, tobacco smoking, withdrawal from smoking and possible surrogates. In: Redmond A, Izard C (eds) Electrophysiological effects of nicotine. Elsevier, Amsterdam, pp 227–243
Porchet HC, Benowitz NL, Sheiner LB (1988) Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 244:231–236
Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797–800
Stolerman IP, Fink R, Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 30:329–342
US Surgeon General's Report (1988) The health consequences of smoking: nicotine addiction. US Government Printing Office, Washington DC
Warburton DM (1990) Psychopharmacological aspects of nicotine. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular and behavioural aspects. Oxford University Press, Oxford
Wesnes K, Warburton DM (1983) Smoking, nicotine and human performance. Pharmacol Ther 21:189–208
West RJ, Jarvis MJ (1986) Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav 25:727–731
West RJ, Russell MAH (1987) Cardiovascular and subjective effects of smoking before and after 24 h abstinence from cigarettes. Psychopharmacology 92:118–121
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Russell, M.A.H., Jarvis, M.J., Jones, G. et al. Non-smokers show acute tolerance to subcutaneous nicotine. Psychopharmacology 102, 56–58 (1990). https://doi.org/10.1007/BF02245744
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245744